BioCentury
ARTICLE | Clinical News

Alisporivir: Phase I started

September 1, 2014 7:00 AM UTC

Novartis began an open-label Phase I trial evaluating alisporivir in combination with EDP-239 in about 42 healthy volunteers. EDP-239, an HCV NS5A protein inhibitor, is in Phase I testing to treat H...